|
12 Nov |
Trump Administration Finalizes The Transparency in Coverage Rule |
|
24 Sep |
HHS OIG Issues Report Critical of Medicare Advantage Risk Adjustment Practices |
|
27 Apr |
Supreme Court Issues Long Awaited Ruling on Affordable Care Act Premium Subsidies |
|
10 Apr |
CMS Issues Guidance on Risk Adjustment and Telehealth Services |
|
19 Mar |
Families First Coronavirus Response Act Imposes Benefit Mandates on Insurers and Group Health Plans |
|
12 Mar |
Medicare Advantage Plans, Medicare Prescription Drug Plans and FEHBP Carriers Take Note: CMS and OPM Announce Actions to Address the Threat of Coronavirus |
|
13 Feb |
Top 10 Provisions of CMS Proposed Rule: Medicare Advantage and Part D Programs for CY2021 and CY2022 |
|
6 Feb |
CMS Proposes Changes to the Medicare Advantage and Part D Programs for CY 2021 and 2022 |
|
27 Dec |
Congress Continues to Focus on Prescription Drug Pricing |
|
26 Jul |
Is Prescription Drug Pricing The Cure For Partisanship? |
